Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoid-induced osteoporosis.

Yasuhiro Tamura1, Hiroko Okinaga, Hiroshi Takami

  • 1Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo 173-8605, Japan. tamu@kt.rim.or.jp

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|October 30, 2004
PubMed
Summary

Long-term glucocorticoid use causes bone loss and increases fracture risk. Bisphosphonates are effective in treating and preventing glucocorticoid-induced osteoporosis and improving bone mineral density.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Androgen Signaling Represses Homeobox C9, an Inhibitor of Androgen Receptor, in Prostate Cancer Cells.

International journal of molecular sciences·2026
Same author

[A Case of Oligometastatic Recurrent Colorectal Liver Metastasis Effectively Treated with Stereotactic Body Radiation Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same author

Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice.

Biochemistry and biophysics reports·2025
Same author

Successful Conversion Surgery for Unresectable Microsatellite Instability-High Pancreatic Tail Cancer Following Pembrolizumab Therapy.

Surgical case reports·2025
Same author

Anthropometric Measures, Recurrent Laryngeal Nerves Diameter, Electromyographic Responses and Vocal Cord Paralysis Risk.

Head & neck·2025
Same author

[A Case of Long-Term Recurrence-Free Survival after Local Resection of Pancreatic Metastasis of Gastric Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·2025

Area of Science:

  • Endocrinology
  • Rheumatology
  • Bone Biology

Background:

  • Glucocorticoids are widely used for various diseases.
  • Long-term use leads to adverse effects, notably osteoporosis.
  • Glucocorticoid-induced osteoporosis (GIO) impairs bone formation and strength.

Purpose of the Study:

  • To review the pathophysiology of GIO.
  • To discuss diagnostic considerations for GIO.
  • To evaluate current and emerging therapeutic strategies for GIO.

Main Methods:

  • Literature review of studies on GIO.
  • Analysis of evidence on diagnostic thresholds for bone mineral density in GIO.
  • Evaluation of treatment efficacy for GIO.

Related Experiment Videos

Main Results:

  • Oral glucocorticoid doses >5 mg/day prednisolone equivalent increase fracture risk within 3-6 months.
  • High-dose inhaled glucocorticoids may also elevate fracture risk.
  • Bisphosphonates are the most effective treatment for GIO, preventing bone loss and reducing fractures.

Conclusions:

  • GIO is a significant complication of glucocorticoid therapy.
  • Diagnosis requires adjusted bone mineral density thresholds.
  • Bisphosphonates are a cornerstone therapy for managing GIO effectively.